ARCHIVES

Phase II Study Cohort Fails To Overcome Erlotinib Resistance

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

DCT Board Approves Concept Of Planning Grants For New Particle Therapy Equipment Development

August 7, 1981

Court Order May Clear Way From Big Landow-Blair-Switch

July 6, 1984

In Brief: Baylor Recruits Scardino, Osborne, 13 Others; Likely To Gain Its Second NCI SPORE Grants

April 30, 1999

NCI Awards $6.7 Million For Breast Cancer Research.

September 8, 2000

Banned Investigator Plans To Resume Clinical Trials Role

August 10, 1990

Imbruvica Improves PFS, OS In Phase III CLL Study

December 26, 2014